Serum VEGF and PGF may be significant markers in prediction of severity of preeclampsia

References

• Garovic VD, August P. Preeclampsia and the future risk of hypertension: the pregnant evidence. Curr Hypertens Rep 2013;15:114–21
   PubMed Web of Science ®Google Scholar
• Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53–6
   PubMed Web of Science ®Google Scholar
• Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002;23:359–72
   PubMed Web of Science ®Google Scholar
• Polliotti BM, Fry AG, Saller DN, et al. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003;101:1266–74
   PubMed Web of Science ®Google Scholar
• Taylor RN, Grimwood J, Taylor RS, et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003;188:177–82
   PubMed Web of Science ®Google Scholar
• Masuyama H, Suwaki N, Nakatsukasa H, et al. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am J Obstet Gynecol 2006;194:551–6
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–58
   PubMed Web of Science ®Google Scholar
• Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A 1993;90:10705–9
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
   PubMed Web of Science ®Google Scholar
• Teixeira PG, Cabral AC, Andrade SP, et al. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension. Hypertens Pregnancy 2008;27:65–73
   PubMed Web of Science ®Google Scholar
• Noori M, Donald AE, Angelakopoulou A, et al. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010;122:478–87
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122
   PubMed Web of Science ®Google Scholar
• ACOG. ACOG Committee Opinion No 579: Definition of term pregnancy. Obstet Gynecol 2013;122:1139
   PubMed Web of Science ®Google Scholar
• Lowry. OH, Rosebrough. NJ, Farr. AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1952;193:265–75
   Web of Science ®Google Scholar
• Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118:1–203
   PubMed Web of Science ®Google Scholar
• Vuorela P, Hatva E, Lymboussaki A, et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997;56:489–94
   PubMed Web of Science ®Google Scholar
• Anthony FW, Evans PW, Wheeler T, et al. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 1997;34:276–80
   PubMed Web of Science ®Google Scholar
• Livingston JC, Chin R, Haddad B, et al. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 2000;183:1554–7
   PubMed Web of Science ®Google Scholar
• Lyall F, Young A, Boswell F, et al. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997;18:269–76
   PubMed Web of Science ®Google Scholar
• Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995;86:815–21
   PubMed Web of Science ®Google Scholar
• Sharkey AM, Cooper JC, Balmforth JR, et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest 1996;26:1182–5
   PubMed Web of Science ®Google Scholar
• Ahmed A, Dunk C, Ahmad S, et al. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen – a review. Placenta 2000;21:16–24
   PubMed Web of Science ®Google Scholar
• Simmons LA, Hennessy A, Gillin AG, Jeremy RW. Uteroplacental blood flow and placental vascular endothelial growth factor in normotensive and pre-eclamptic pregnancy. BJOG 2000;107:678–85
   PubMed Web of Science ®Google Scholar
• Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002;160:1405–23
   PubMed Web of Science ®Google Scholar
• Sgambati E, Marini M, Zappoli Thyrion GD, et al. VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG 2004;111:564–70
   PubMed Web of Science ®Google Scholar
• Varughese B, Bhatla N, Kumar R, et al. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia. Natl Med J India 2010;23:77–81
   PubMed Web of Science ®Google Scholar
• Semczuk-Sikora A, Krzyzanowski A, Kwiatek M, et al. Maternal serum concentration of placental growth factor (PIGF) and endothelial growth factor (VEGF) in pregnancies complicated by preeclampsia. Ginekol Pol 2007;78:873–6
   PubMedGoogle Scholar
• Reuvekamp A, Velsing-Aarts FV, Poulina IE, et al. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1999;106:1019–22
   PubMedGoogle Scholar
• Weed S, Bastek JA, Anton L, et al. Examining the correlation between placental and serum placenta growth factor in preeclampsia. Am J Obstet Gynecol 2012;207:140.e1–6
   PubMed Web of Science ®Google Scholar
• Youssef A, Righetti F, Morano D, et al. Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11+0 to 13+6 weeks in the prediction of late (>34 weeks) pre-eclampsia. Prenat Diagn 2011;31:1141–6
   PubMed Web of Science ®Google Scholar
• Dover N, Gulerman HC, Celen S, et al. Placental growth factor: as an early second trimester predictive marker for preeclampsia in normal and high-risk pregnancies in a Turkish population. J Obstet Gynaecol India 2013;63:158–63
   PubMedGoogle Scholar